STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Bakkt Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Bakkt Holdings, Inc. (BKKT)

The vested performance stock units are part of an inducement grant that can vest over a three-year performance period starting March 21, 2025, based on the stock’s 90-day volume-weighted average price appreciating at least 100% above a $9.33 reference price, with additional vesting in set tranches for further stock price appreciation. The filing also reflects stock options covering 1,308,725 shares of Class A Common Stock at an exercise price of $10 per share, structured in quarterly tranches with specific exercise and lock-up conditions.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Naheta Akshay Sudhir

(Last) (First) (Middle)
C/O BAKKT HOLDINGS, INC.
1 LIBERTY ST FL 3 STE 305-306

(Street)
NEW YORK NY 10006

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bakkt Holdings, Inc. [ BKKT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO and President
3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/14/2025 M 803,861(1) A $0 1,098,577(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Units (3) 11/14/2025 M 803,861 (4)(5) 03/21/2028 Class A Common Stock 803,861 $0 803,856 D
Stock Option (right to buy) $10 (6)(7)(8) (6)(7)(8) Class A Common Stock 1,308,725 1,308,725 D
Explanation of Responses:
1. The reported transaction reflects the vesting of performance stock units ("PSUs") upon the determination that the applicable performance conditions were satisfied.
2. Includes 11,426 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock. The RSUs will vest on March 21, 2026, subject to the reporting person's continued employment with the issuer as of the vesting date.
3. These securities are an inducement grant of PSUs. Each PSU represents a contingent right to receive one share of the issuer's Class A Common Stock.
4. The PSUs shall be eligible to vest over a three-year performance period following March 21, 2025 (the "Vesting Commencement Date") based on attainment of certain stock price metrics as provided below (the "Performance Period"). A total of 535,909 of the total PSUs will vest, subject to the reporting person's continued employment with the issuer through such vesting date, if the issuer's stock price (measured based on a rolling 90-day volume-weighted average price "VWAP") appreciates at any point during the Performance Period by100% above $9.33 per share (the "Reference Price"). [Continued to footnote 5]
5. [Continued from footnote 4] For each additional 25% of stock price appreciation (measured based on a rolling 90-day VWAP) above the Reference Price during the Performance Period, limited to a maximum of eight (8) additional vesting tranches, an additional 133,976PSUs will vest, subject to the reporting person's continued employment with the issuer through such vesting date. No PSUs will vest in the event that the issuer's stock price (measured based on a rolling 90-day VWAP) does not appreciate above the Reference Price by at least 100% during the Performance Period. Any PSUs that satisfy the above vesting conditions prior to the first anniversary of the Vesting Commencement Date will not vest unless and until the first anniversary of the Vesting Commencement Date.
6. Represent stock options to purchase shares of the issuer's Class A Common Stock ("Options") granted on July 29, 2025, contingent on the issuer's shareholder approval, which was obtained on October 31, 2025. The Options are a commitment by the grantee to exercise a predetermined number of Options every quarter for eight quarters (the "Committed Options") at an exercise price per share equal to $10,00, which reflects the fair market value of a share of Class A Common Stock on the grant date. If the reporting person does not exercise the Committed Options in any quarter, then all remaining Options are forfeited. One-eighth of the Options will become exercisable each quarter (each, a "Quarterly Tranche"). [Continued to footnote 7]
7. [Continued from footnote 6] The Committed Options will be exercisable over a two-day period in the applicable quarter (the "Exercise Period"); provided that if the Exercise Period for a Quarterly Tranche occurs during a blackout period, then such Exercise Period shall instead be the next quarterly Exercise Period. If the reporting person exercises the Committed Option portion, the remainder of that Quarterly Tranche (the "Optional Exercise Options") will become exercisable for a period of one year. The Optional Exercise Option portion of any Quarterly Tranche will expire at the end of such one-year period. [Continued to footnote 8]
8. [Continued from footnote 7] Notwithstanding the foregoing exercise schedule, following the first quarter after stockholder approval of the Options, any portion of the Options may be exercised earlier than the applicable quarter, provided that shares of Class A Common Stock acquired on exercise of the Optional Exercise Options will be subject to a lock-up period so that the shares acquired on exercise may not be sold or transferred until the originally-scheduled exercise date.
s/ Marc D'Annunzio Attorney-in-Fact for Akshay Sudhir Naheta 11/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Bakkt (BKKT) report in this Form 4?

Bakkt reported that CEO and President Akshay Sudhir Naheta had 803,861 performance stock units vest on 11/14/2025, which were settled in shares of Class A Common Stock at a reported price of $0.

How many Bakkt (BKKT) shares does the reporting person hold after this transaction?

Following the reported transaction, Akshay Sudhir Naheta beneficially owns 1,098,577 shares of Bakkt Class A Common Stock directly, which includes 11,426 restricted stock units.

What are the vesting terms for the restricted stock units (RSUs) reported for Bakkt (BKKT)?

The filing states that 11,426 RSUs each represent a contingent right to receive one share of Class A Common Stock and will vest on March 21, 2026, subject to the reporting person’s continued employment with Bakkt through that date.

How do the performance stock units (PSUs) for Bakkt (BKKT) vest?

The PSUs are eligible to vest over a three-year performance period starting March 21, 2025 if Bakkt’s stock price, measured on a rolling 90-day VWAP basis, appreciates at least 100% above $9.33 per share. An initial 535,909 PSUs vest at that level, with additional tranches of 133,976 PSUs for each further 25% appreciation, up to eight additional tranches, all subject to continued employment.

What happens if Bakkt’s stock does not reach the PSU performance targets?

The disclosure explains that no PSUs will vest if Bakkt’s stock price, based on a rolling 90-day VWAP, does not appreciate at least 100% above the $9.33 reference price during the performance period.

What stock options did the Bakkt (BKKT) executive receive and on what terms?

The filing reports stock options to purchase 1,308,725 shares of Bakkt Class A Common Stock at an exercise price of $10 per share, granted on July 29, 2025 contingent on shareholder approval, which was obtained on October 31, 2025. One-eighth of the options is scheduled to become exercisable each quarter, with a structure that requires exercise of a committed portion in a short exercise window each quarter for the remaining options to stay outstanding.

Are there any lock-up or timing restrictions on exercising the Bakkt (BKKT) stock options?

The disclosure notes that after the first quarter following shareholder approval, any portion of the options may be exercised earlier than the scheduled quarter, but shares acquired on exercise of the applicable options will be subject to a lock-up period so they cannot be sold or transferred until the originally scheduled exercise date.

Bakkt Holdings Inc

NYSE:BKKT

BKKT Rankings

BKKT Latest News

BKKT Latest SEC Filings

BKKT Stock Data

403.61M
15.71M
12.72%
22.3%
17.98%
Software - Infrastructure
Finance Services
Link
United States
NEW YORK